malondialdehyde has been researched along with 2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, TJ; Berger, JP; Howarth, AG; Jiang, Y; Pannirselvam, M; Severson, D; Triggle, CR; Wiehler, WB | 1 |
1 other study(ies) available for malondialdehyde and 2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
| Article | Year |
|---|---|
A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
Topics: Acetates; Adrenergic alpha-Agonists; Animals; Blood Glucose; Blotting, Western; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Hypoglycemic Agents; Indoles; Lipid Peroxidation; Male; Malondialdehyde; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Phenylephrine; PPAR gamma; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |